Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNCA - Palisade Bio to begin trading on Nasdaq today

SNCA - Palisade Bio to begin trading on Nasdaq today

Neuralstem Inc.
Palisade Bio (PALI), formed by the reverse merger of Seneca BioSciences (SNCA) and privately held Leading BioSciences, will begin trading on the Nasdaq today.A concurrent $20M investment was led by Altium Capital as part of the merger.Palisades is focusing on drugs for gastrointestinal conditions.The company's sole pipeline product, LB1148, is an oral broad-spectrum protease inhibitor for multiple indications in phase 2.Palisade intends for LB1148 to compete against Merck's Entereg (alvimopan)Palisade will host a conference call at 11a ET today.

For further details see:

Palisade Bio to begin trading on Nasdaq today
Stock Information
Company Name: Neuralstem Inc.
Stock Symbol: SNCA
Market: NYSE
Menu
SNCA SNCA Quote SNCA Short SNCA News SNCA Articles SNCA Message Board
Get SNCA Alerts

News, Short Squeeze, Breakout and More Instantly...